Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortTablet that blocks testosterone in prostate cancer.Hormone therapy that has saved hundreds of thousands from breast cancer.
Body systemCancerCancer
Drug classAndrogen receptor inhibitorsSelective oestrogen receptor modulators
SupplyPrescription onlyPrescription onlyWHO essential medicine
Main usesAdvanced and metastatic prostate cancer, High-risk non-metastatic prostate cancerHormone-receptor-positive breast cancer (pre- and post-menopause), Breast cancer prevention in high risk, Male breast cancer
How it worksStops testosterone driving prostate cancer growth.Stops oestrogen fuelling breast cancer cells.
Starts working——
Half-lifeAbout 6 days5–7 days
Typical adult dose160 mg once a day.20 mg once a day for 5–10 years.
FormsCapsule, TabletTablet, Oral solution
Common side effectsFatigue, Hot flushes, High blood pressure, FallsHot flushes, Vaginal discharge, Irregular periods, Mood changes
Serious side effectsSeizures, Heart events, FracturesBlood clots, Womb cancer (post-menopause), Stroke, Cataracts
Don't take if—Pregnancy; History of blood clots (caution); Taking potent CYP2D6 inhibitors (paroxetine, fluoxetine) — reduces effect; Undiagnosed vaginal bleeding
Alcohol—Usually no problem in moderation. No specific interaction.
PregnancyUsually avoidedCondoms required with a pregnant partner.Usually avoidedCan harm the fetus; avoid pregnancy for 2 months after stopping.
Breastfeeding—Usually avoidedAvoid.
In use since20121973
Brand namesUnited States: XtandiUnited Kingdom: XtandiIndia: Xtandi, BdenzaUnited States: SoltamoxUnited Kingdom: Nolvadex-D, SoltamoxIndia: Tamodex, Mamofen
Legal status—United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H
ATC codeL02BB04L02BA01

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker